Sub menu

 
 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

1062 result(s) found, displaying 826 to 850

  • AusPAR: Pazopanib hydrochloride

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Pazopanib hydrochloride

  • AusPAR: Imatinib (as mesylate)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Imatinib (as mesylate)

  • AusPAR: Exenatide

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Exenatide

  • AusPAR: Docetaxel

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Docetaxel

  • AusPAR: Everolimus

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Everolimus

  • AusPAR: Voriconazole

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Voriconazole

  • AusPAR: Eribulin mesilate

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Eribulin mesilate

  • AusPAR: Everolimus

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Everolimus

  • AusPAR: Exenatide

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Exenatide

  • AusPAR: Sitagliptin / Metformin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Sitagliptin / Metformin

  • AusPAR: Ezetimibe

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ezetimibe

  • AusPAR: Olmesartan medoxomil

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Olmesartan medoxomil

  • AusPAR: Somatropin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Somatropin

  • AusPAR: Rifaximin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Rifaximin

  • AusPAR: Cyclizine lactate

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Cyclizine lactate

  • AusPAR: Ibuprofen

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ibuprofen

  • AusPAR: Erlotinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Erlotinib

  • AusPAR: Strontium ranelate

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Strontium ranelate

  • AusPAR: Bortezomib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Bortezomib

Help us improve the Therapeutic Goods Administration site